| Home
| Contact Us | NAV & Stock Price | Monthly Portfolio Summary Ellsworth Convertible Growth and Income Fund
Announces Dividend, Earnings and Financial Update
FOR IMMEDIATE RELEASE
Morristown, NJ
January 13, 2006
Cusip 289074106 |
For Information:
Joshua P. Lake
(973) 631-1177 |
Ellsworth Convertible Growth and Income Fund, Inc.
(AMEX - ECF) today reported financial highlights and certain portfolio information for the
three months ended December 31, 2005.
The Fund declared its seventy-eighth quarterly dividend
today:
|
|
Payable date |
|
Record date |
$0.07 per share
from ordinary income |
 |
February 27, 2006 |
|
February 13, 2006 |
| |
Three Months Ended
December 31 |
| Earnings Report |
2005 |
2004 |
| Net Income |
$942,000 |
$897,000 |
| Per Share |
$0.08 |
$0.07 |
| Shares Outstanding |
12,429,083 |
12,362,269 |
| Total Net Assets |
$113,113,000 |
$112,161,000 |
| Net Asset Value Per Share |
$9.10 |
$9.07 |
| Fund
Statistics as of December 31, 2005 |
|
Top Ten Holdings by underlying common stock as of December 31, 2005 |
|
|
|
|
|
|
|
% of |
| Market price |
|
|
$7.80 |
|
|
|
Net Assets |
| Net asset value
(NAV) |
|
$9.10 |
|
The Walt Disney Company |
2.9 |
| Premium/(Discount) |
|
(14.29)% |
|
Nuveen Investments, Inc. |
|
2.5 |
| Total Net Assets |
|
$113,113,000 |
|
Chesapeake Energy corp. |
|
2.2 |
| 12-Month income distribution |
$0.3075 |
|
Genworth Financial, Inc. |
2.2 |
| Yield on market price |
|
3.94% |
|
The
St. Paul Travelers Companies, Inc. |
2.2 |
| Ratio of expenses |
|
1.33%* |
|
Teva Pharmaceuticals Industries
Ltd. |
|
2.2 |
| Ratio of
net income |
|
|
3.35%* |
|
Freeport-McMoRan
Copper and Gold, Inc. |
2.1 |
| Portfolio Turnover |
|
13.87% |
|
The TJX Companies, Inc. |
2.1 |
| Shares
outstanding |
|
|
12,429,083 |
|
Celanese Corp. |
2.0 |
| * Annualized |
|
|
|
MetLife, Inc. |
2.0 |
|
|
|
|
|
|
|
| Major Industry Exposure |
|
|
% of |
|
Portfolio Ratings from Moody's |
|
|
| as of December 31, 2005 |
|
|
Net Assets |
|
as of December 31, 2005 |
|
|
| Financial and Insurance |
|
|
17.9 |
|
(From S&P when Moody's
is unavailable) |
|
% of
Portfolio |
| Technology |
|
12.6 |
|
Aa |
|
11 |
| Pharmaceuticals |
|
|
10.6 |
|
A |
|
9 |
| Energy |
|
|
10.3 |
|
Baa |
|
23 |
| Banking/Savings and Loan |
|
7.3 |
|
Ba |
|
9 |
| Health Care |
|
|
5.5 |
|
B |
|
23 |
| Telecommunications |
|
|
4.9 |
|
NR |
|
25 |
| Retail |
|
|
4.9 |
|
|
|
|
| Entertainment |
|
|
4.2 |
|
|
|
|
| Chemicals |
|
|
3.4 |
|
|
|
|
|
|
|
|
|
|
|
|
| Asset Allocation |
|
|
% of |
|
|
|
|
| as of December 31, 2005 |
|
|
Net
Assets |
|
|
|
|
| Convertible Bonds & Notes |
|
|
50.5 |
|
|
|
|
| Convertible Preferred Stock |
|
|
23.1 |
|
|
|
|
| Mandatory Conv. Securities |
|
|
18.8 |
|
|
|
|
| Common Stock |
|
|
4.1 |
|
|
|
|
| Short-term Securities |
|
|
2.8 |
|
|
|
|
| Other Assets |
|
|
0.7 |
|
|
|
|
Data is unaudited and as of December 31, 2005. This
selected information should be read in conjunction with the financial statements and notes
included in the Company's Annual Report to Stockholders for the twelve months ended
September 30, 2005.
Detailed portfolio information is available on our website (http://www.ellsworthfund.com). Visit us there or
contact us by e-mail at info@ellsworthfund.com
or call us at (973) 631-1177.
Ellsworth is a diversified closed-end management investment company. Ellsworth's
investment objective is to seek a high level of total return on its assets through a
combination of current income and capital appreciation. It seeks to achieve this objective
by investing primarily in convertible securities.
Financial
Update (PDF 39Kb) | Press Releases | Dividend History | Home |